{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:27:55Z","timestamp":1794612475386,"version":"4.9.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Studies over the last 100\u00a0years have suggested a link between inflammation, infectious disease, and Alzheimer\u2019s Disease (AD). Understanding how the immune system changes during the development of AD may facilitate new treatments. Here, we studied an aging cohort who had been assessed for AD pathology with amyloid positron emission tomography and cognitive testing, and conducted high dimensional flow cytometry on peripheral blood mononuclear and cerebrospinal fluid cells. Participants were assigned a classification of being amyloid negative cognitively normal, amyloid positive cognitively normal (APCN), or amyloid positive mild cognitive impairment (APMCI), an early stage of AD. We observed major alterations in the peripheral innate immune system including increased myeloid and plasmacytoid dendritic cells in the blood of APMCI participants. When the adaptive immune system was examined, amyloid positive participants, regardless of cognitive status, had increased CD3\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Further analyses of CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells revealed that APMCI participants had an increase in more differentiated phenotype T cells, such as effector memory and effector memory CD45RA expressing (TEMRA), compared to those with normal cognition. When T cell function was measured, we observed that T cells from APCN participants had increased IFN\u03b3\n                    <jats:sup>+<\/jats:sup>\n                    GzB\n                    <jats:sup>-<\/jats:sup>\n                    producing cells compared to the other participants. In contrast, we demonstrate that APMCI participants had a major increase in T cells that lacked cytokine production following restimulation and expressed increased levels of PD-1 and Tox, suggesting these are exhausted cells. Rejuvenation of these cells may provide a potential treatment for AD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-42708-8","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T06:03:01Z","timestamp":1695362581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["T cell exhaustion is associated with cognitive status and amyloid accumulation in Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Jason M.","family":"Grayson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Jiah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn","family":"Marsac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecillia S.","family":"Lindestam Arlehamn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan I.","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel N.","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"key":"42708_CR1","doi-asserted-by":"publisher","unstructured":"2021 Alzheimer's disease facts and figures. Alzheimers Dement 17, 327-406, doi:https:\/\/doi.org\/10.1002\/alz.12328 (2021).","DOI":"10.1002\/alz.12328"},{"key":"42708_CR2","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.37765\/ajmc.2022.89236","volume":"28","author":"AP Skaria","year":"2022","unstructured":"Skaria, A. P. The economic and societal burden of Alzheimer disease: Managed care considerations. Am. J. Manag. Care 28, S188\u2013S196. https:\/\/doi.org\/10.37765\/ajmc.2022.89236 (2022).","journal-title":"Am. J. Manag. Care"},{"key":"42708_CR3","doi-asserted-by":"publisher","first-page":"S177","DOI":"10.37765\/ajmc.2020.88482","volume":"26","author":"W Wong","year":"2020","unstructured":"Wong, W. Economic burden of Alzheimer disease and managed care considerations. Am. J. Manag. Care 26, S177\u2013S183. https:\/\/doi.org\/10.37765\/ajmc.2020.88482 (2020).","journal-title":"Am. J. Manag. Care"},{"key":"42708_CR4","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.3389\/fneur.2019.01312","volume":"10","author":"L Fan","year":"2019","unstructured":"Fan, L. et al. New insights into the pathogenesis of Alzheimer\u2019s disease. Front. Neurol. 10, 1312. https:\/\/doi.org\/10.3389\/fneur.2019.01312 (2019).","journal-title":"Front. Neurol."},{"key":"42708_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1055\/s-0039-1678581","volume":"39","author":"A Atri","year":"2019","unstructured":"Atri, A. Current and future treatments in Alzheimer\u2019s disease. Semin Neurol 39, 227\u2013240. https:\/\/doi.org\/10.1055\/s-0039-1678581 (2019).","journal-title":"Semin Neurol"},{"key":"42708_CR6","doi-asserted-by":"publisher","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin, W. S. et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 7611\u20137615. https:\/\/doi.org\/10.1073\/pnas.86.19.7611 (1989).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"42708_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/BF00310142","volume":"81","author":"HM Wisniewski","year":"1991","unstructured":"Wisniewski, H. M., Barcikowska, M. & Kida, E. Phagocytosis of beta\/A4 amyloid fibrils of the neuritic neocortical plaques. Acta Neuropathol. 81, 588\u2013590. https:\/\/doi.org\/10.1007\/BF00310142 (1991).","journal-title":"Acta Neuropathol."},{"key":"42708_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1212\/wnl.44.2.227","volume":"44","author":"JC Breitner","year":"1994","unstructured":"Breitner, J. C. et al. Inverse association of anti-inflammatory treatments and Alzheimer\u2019s disease: initial results of a co-twin control study. Neurology 44, 227\u2013232. https:\/\/doi.org\/10.1212\/wnl.44.2.227 (1994).","journal-title":"Neurology"},{"key":"42708_CR9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jalz.2010.12.014","volume":"7","author":"JC Breitner","year":"2011","unstructured":"Breitner, J. C. et al. Extended results of the Alzheimer\u2019s disease anti-inflammatory prevention trial. Alzheimers Dement 7, 402\u2013411. https:\/\/doi.org\/10.1016\/j.jalz.2010.12.014 (2011).","journal-title":"Alzheimers Dement"},{"key":"42708_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s00406-021-01286-4","volume":"272","author":"RF Damiano","year":"2022","unstructured":"Damiano, R. F. et al. Cognitive decline following acute viral infections: Literature review and projections for post-COVID-19. Eur. Arch. Psychiatry Clin. Neurosci. 272, 139\u2013154. https:\/\/doi.org\/10.1007\/s00406-021-01286-4 (2022).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"42708_CR11","doi-asserted-by":"publisher","first-page":"e016522","DOI":"10.1136\/bmjopen-2017-016522","volume":"7","author":"C Warren-Gash","year":"2017","unstructured":"Warren-Gash, C. et al. Association between human herpesvirus infections and dementia or mild cognitive impairment: A systematic review protocol. BMJ Open 7, e016522. https:\/\/doi.org\/10.1136\/bmjopen-2017-016522 (2017).","journal-title":"BMJ Open"},{"key":"42708_CR12","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1038\/s41598-019-41218-w","volume":"9","author":"C Warren-Gash","year":"2019","unstructured":"Warren-Gash, C. et al. Human herpesvirus infections and dementia or mild cognitive impairment: A systematic review and meta-analysis. Sci. Rep. 9, 4743. https:\/\/doi.org\/10.1038\/s41598-019-41218-w (2019).","journal-title":"Sci. Rep."},{"key":"42708_CR13","first-page":"43","volume":"1","author":"SP Adler","year":"1992","unstructured":"Adler, S. P. Hospital transmission of cytomegalovirus. Infect. Agents Dis. 1, 43\u201349 (1992).","journal-title":"Infect. Agents Dis."},{"key":"42708_CR14","first-page":"109","volume":"7","author":"SP Adler","year":"1992","unstructured":"Adler, S. P. Cytomegalovirus transmission and child day care. Adv. Pediatr. Infect. Dis. 7, 109\u2013122 (1992).","journal-title":"Adv. Pediatr. Infect. Dis."},{"key":"42708_CR15","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.1016\/j.vaccine.2013.08.077","volume":"31","author":"C Conde-Glez","year":"2013","unstructured":"Conde-Glez, C. et al. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine 31, 5067\u20135074. https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.077 (2013).","journal-title":"Vaccine"},{"key":"42708_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/pai.12030","volume":"24","author":"HM Hesla","year":"2013","unstructured":"Hesla, H. M. et al. Herpesvirus infections and allergic sensitization in children of families with anthroposophic and non-anthroposophic lifestyle\u2013the ALADDIN birth cohort. Pediatr. Allergy Immunol. 24, 61\u201365. https:\/\/doi.org\/10.1111\/pai.12030 (2013).","journal-title":"Pediatr. Allergy Immunol."},{"key":"42708_CR17","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/01.wnl.0000247665.94088.8d","volume":"67","author":"D Pohl","year":"2006","unstructured":"Pohl, D. et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology 67, 2063\u20132065. https:\/\/doi.org\/10.1212\/01.wnl.0000247665.94088.8d (2006).","journal-title":"Neurology"},{"key":"42708_CR18","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3390\/v4071116","volume":"4","author":"N Torti","year":"2012","unstructured":"Torti, N. & Oxenius, A. T cell memory in the context of persistent herpes viral infections. Viruses 4, 1116\u20131143. https:\/\/doi.org\/10.3390\/v4071116 (2012).","journal-title":"Viruses"},{"key":"42708_CR19","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.1042\/bst019122s","volume":"19","author":"GA Jamieson","year":"1991","unstructured":"Jamieson, G. A., Maitland, N. J., Craske, J., Wilcock, G. K. & Itzhaki, R. F. Detection of herpes simplex virus type 1 DNA sequences in normal and Alzheimer\u2019s disease brain using polymerase chain reaction. Biochem. Soc. Trans. 19, 122S. https:\/\/doi.org\/10.1042\/bst019122s (1991).","journal-title":"Biochem. Soc. Trans."},{"key":"42708_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jmv.1890330403","volume":"33","author":"GA Jamieson","year":"1991","unstructured":"Jamieson, G. A., Maitland, N. J., Wilcock, G. K., Craske, J. & Itzhaki, R. F. Latent herpes simplex virus type 1 in normal and Alzheimer\u2019s disease brains. J. Med. Virol. 33, 224\u2013227. https:\/\/doi.org\/10.1002\/jmv.1890330403 (1991).","journal-title":"J. Med. Virol."},{"key":"42708_CR21","doi-asserted-by":"publisher","first-page":"e1007617","DOI":"10.1371\/journal.ppat.1007617","volume":"15","author":"G De Chiara","year":"2019","unstructured":"De Chiara, G. et al. Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice. PLoS Pathog. 15, e1007617. https:\/\/doi.org\/10.1371\/journal.ppat.1007617 (2019).","journal-title":"PLoS Pathog."},{"key":"42708_CR22","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.16m11312","author":"VC Chen","year":"2018","unstructured":"Chen, V. C. et al. Herpes Zoster and Dementia: A Nationwide Population-Based Cohort Study. J. Clin. Psychiatry https:\/\/doi.org\/10.4088\/JCP.16m11312 (2018).","journal-title":"J. Clin. Psychiatry"},{"key":"42708_CR23","doi-asserted-by":"publisher","first-page":"e0188490","DOI":"10.1371\/journal.pone.0188490","volume":"12","author":"MC Tsai","year":"2017","unstructured":"Tsai, M. C. et al. Increased risk of dementia following herpes zoster ophthalmicus. PLoS ONE 12, e0188490. https:\/\/doi.org\/10.1371\/journal.pone.0188490 (2017).","journal-title":"PLoS ONE"},{"key":"42708_CR24","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuron.2019.12.031","volume":"105","author":"MA Allnutt","year":"2020","unstructured":"Allnutt, M. A. et al. Human herpesvirus 6 detection in Alzheimer\u2019s disease cases and controls across multiple cohorts. Neuron 105, 1027-1035 e1022. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.031 (2020).","journal-title":"Neuron"},{"key":"42708_CR25","doi-asserted-by":"publisher","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","volume":"5","author":"SS Dominy","year":"2019","unstructured":"Dominy, S. S. et al. Porphyromonas gingivalis in Alzheimer\u2019s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci. Adv. 5, eaau3333. https:\/\/doi.org\/10.1126\/sciadv.aau3333 (2019).","journal-title":"Sci. Adv."},{"key":"42708_CR26","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41598-022-06749-9","volume":"12","author":"A Chacko","year":"2022","unstructured":"Chacko, A. et al. Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer\u2019s disease risk. Sci. Rep. 12, 2759. https:\/\/doi.org\/10.1038\/s41598-022-06749-9 (2022).","journal-title":"Sci. Rep."},{"key":"42708_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12974-018-1086-8","volume":"15","author":"L Torres","year":"2018","unstructured":"Torres, L. et al. Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer\u2019s disease in wild-type, C57BL\/6 mice. J. Neuroinflammation 15, 57. https:\/\/doi.org\/10.1186\/s12974-018-1086-8 (2018).","journal-title":"J. Neuroinflammation"},{"key":"42708_CR28","first-page":"1495","volume":"165","author":"R Verreault","year":"2001","unstructured":"Verreault, R., Laurin, D., Lindsay, J. & De Serres, G. Past exposure to vaccines and subsequent risk of Alzheimer\u2019s disease. CMAJ 165, 1495\u20131498 (2001).","journal-title":"CMAJ"},{"key":"42708_CR29","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3233\/JAD-220361","volume":"88","author":"AS Bukhbinder","year":"2022","unstructured":"Bukhbinder, A. S. et al. Risk of Alzheimer\u2019s disease following influenza vaccination: A claims-based cohort study using propensity score matching. J. Alzheimers Dis. 88, 1061\u20131074. https:\/\/doi.org\/10.3233\/JAD-220361 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"42708_CR30","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1016\/j.vaccine.2021.08.046","volume":"39","author":"TL Wiemken","year":"2021","unstructured":"Wiemken, T. L. et al. Dementia risk following influenza vaccination in a large veteran cohort. Vaccine 39, 5524\u20135531. https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.046 (2021).","journal-title":"Vaccine"},{"key":"42708_CR31","doi-asserted-by":"publisher","first-page":"e12293","DOI":"10.1002\/trc2.12293","volume":"8","author":"C Schnier","year":"2022","unstructured":"Schnier, C., Janbek, J., Lathe, R. & Haas, J. Reduced dementia incidence after varicella zoster vaccination in Wales 2013\u20132020. Alzheimers Dement (N Y) 8, e12293. https:\/\/doi.org\/10.1002\/trc2.12293 (2022).","journal-title":"Alzheimers Dement (N Y)"},{"key":"42708_CR32","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000530","author":"D Makrakis","year":"2022","unstructured":"Makrakis, D. et al. Intravesical BCG and incidence of Alzheimer disease in patients with bladder cancer: Results from an administrative dataset. Alzheimer Dis. Assoc. Disord. https:\/\/doi.org\/10.1097\/WAD.0000000000000530 (2022).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"42708_CR33","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1016\/j.clgc.2021.05.001","volume":"19","author":"JI Kim","year":"2021","unstructured":"Kim, J. I. et al. Intravesical bacillus calmette-guerin treatment is inversely associated with the risk of developing Alzheimer disease or other dementia among patients with non-muscle-invasive bladder cancer. Clin. Genitourin. Cancer 19, e409\u2013e416. https:\/\/doi.org\/10.1016\/j.clgc.2021.05.001 (2021).","journal-title":"Clin. Genitourin. Cancer"},{"key":"42708_CR34","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1172\/JCI133737","volume":"130","author":"ER Roy","year":"2020","unstructured":"Roy, E. R. et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J. Clin. Invest. 130, 1912\u20131930. https:\/\/doi.org\/10.1172\/JCI133737 (2020).","journal-title":"J. Clin. Invest."},{"key":"42708_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate, D. et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer\u2019s disease. Nature 577, 399\u2013404. https:\/\/doi.org\/10.1038\/s41586-019-1895-7 (2020).","journal-title":"Nature"},{"key":"42708_CR36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489-1501 e1415. https:\/\/doi.org\/10.1016\/j.cell.2020.05.015 (2020).","journal-title":"Cell"},{"key":"42708_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12974-016-0483-0","volume":"13","author":"A Ciaramella","year":"2016","unstructured":"Ciaramella, A. et al. Myeloid dendritic cells are decreased in peripheral blood of Alzheimer\u2019s disease patients in association with disease progression and severity of depressive symptoms. J. Neuroinflammation 13, 18. https:\/\/doi.org\/10.1186\/s12974-016-0483-0 (2016).","journal-title":"J. Neuroinflammation"},{"key":"42708_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/s0165-5728(99)00046-6","volume":"97","author":"VR Lombardi","year":"1999","unstructured":"Lombardi, V. R., Garcia, M., Rey, L. & Cacabelos, R. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer\u2019s disease (AD) individuals. J. Neuroimmunol. 97, 163\u2013171. https:\/\/doi.org\/10.1016\/s0165-5728(99)00046-6 (1999).","journal-title":"J. Neuroimmunol."},{"key":"42708_CR39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/s0165-5728(02)00309-0","volume":"132","author":"J Tan","year":"2002","unstructured":"Tan, J. et al. CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer\u2019s disease. J. Neuroimmunol. 132, 164\u2013172. https:\/\/doi.org\/10.1016\/s0165-5728(02)00309-0 (2002).","journal-title":"J. Neuroimmunol."},{"key":"42708_CR40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.neurobiolaging.2006.05.020","volume":"28","author":"L Speciale","year":"2007","unstructured":"Speciale, L. et al. Lymphocyte subset patterns and cytokine production in Alzheimer\u2019s disease patients. Neurobiol. Aging 28, 1163\u20131169. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2006.05.020 (2007).","journal-title":"Neurobiol. Aging"},{"key":"42708_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-2009-1015","volume":"17","author":"A Larbi","year":"2009","unstructured":"Larbi, A. et al. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer\u2019s disease. J. Alzheimers Dis. 17, 91\u2013103. https:\/\/doi.org\/10.3233\/JAD-2009-1015 (2009).","journal-title":"J. Alzheimers Dis."},{"key":"42708_CR42","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001106","author":"C Joshi","year":"2022","unstructured":"Joshi, C. et al. CSF-Derived CD4(+) T-cell diversity is reduced in patients with alzheimer clinical syndrome. Neurol. Neuroimmunol. Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001106 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"42708_CR43","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","volume":"188","author":"AJ Zajac","year":"1998","unstructured":"Zajac, A. J. et al. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 188, 2205\u20132213. https:\/\/doi.org\/10.1084\/jem.188.12.2205 (1998).","journal-title":"J. Exp. Med."},{"key":"42708_CR44","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber, D. L. et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439, 682\u2013687. https:\/\/doi.org\/10.1038\/nature04444 (2006).","journal-title":"Nature"},{"key":"42708_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13578-022-00897-1","volume":"12","author":"CT Wu","year":"2022","unstructured":"Wu, C. T. et al. A change of PD-1\/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer\u2019s disease. Cell Biosci. 12, 162. https:\/\/doi.org\/10.1186\/s13578-022-00897-1 (2022).","journal-title":"Cell Biosci."},{"key":"42708_CR46","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.immuni.2019.09.013","volume":"51","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. TCF-1-centered transcriptional network drives an effector versus exhausteD CD8 T cell-fate decision. Immunity 51, 840-855 e845. https:\/\/doi.org\/10.1016\/j.immuni.2019.09.013 (2019).","journal-title":"Immunity"},{"key":"42708_CR47","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.4049\/jimmunol.1800716","volume":"201","author":"M Miron","year":"2018","unstructured":"Miron, M. et al. Human lymph nodes maintain TCF-1(hi) memory T cells with high functional potential and clonal diversity throughout life. J. Immunol. 201, 2132\u20132140. https:\/\/doi.org\/10.4049\/jimmunol.1800716 (2018).","journal-title":"J. Immunol."},{"key":"42708_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","volume":"571","author":"O Khan","year":"2019","unstructured":"Khan, O. et al. TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Nature 571, 211\u2013218. https:\/\/doi.org\/10.1038\/s41586-019-1325-x (2019).","journal-title":"Nature"},{"key":"42708_CR49","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nm.4022","volume":"22","author":"K Baruch","year":"2016","unstructured":"Baruch, K. et al. PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer\u2019s disease. Nat. Med. 22, 135\u2013137. https:\/\/doi.org\/10.1038\/nm.4022 (2016).","journal-title":"Nat. Med."},{"key":"42708_CR50","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi, M. et al. Infiltrating CD8(+) T cells exacerbate Alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat. Neurosci. 26, 1489\u20131504. https:\/\/doi.org\/10.1038\/s41593-023-01415-3 (2023).","journal-title":"Nat. Neurosci."},{"key":"42708_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.12.019","volume":"76","author":"R Taipa","year":"2019","unstructured":"Taipa, R. et al. Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer\u2019s disease and their correlation with cognitive decline. Neurobiol. Aging 76, 125\u2013132. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.12.019 (2019).","journal-title":"Neurobiol. Aging"},{"key":"42708_CR52","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/alz.12399","volume":"18","author":"HS Yang","year":"2022","unstructured":"Yang, H. S. et al. Plasma IL-12\/IFN-gamma axis predicts cognitive trajectories in cognitively unimpaired older adults. Alzheimers Dement 18, 645\u2013653. https:\/\/doi.org\/10.1002\/alz.12399 (2022).","journal-title":"Alzheimers Dement"},{"key":"42708_CR53","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s00259-020-05174-2","volume":"48","author":"LE Collij","year":"2021","unstructured":"Collij, L. E. et al. Visual assessment of [(18)F]flutemetamol PET images can detect early amyloid pathology and grade its extent. Eur. J. Nucl. Med. Mol. Imaging 48, 2169\u20132182. https:\/\/doi.org\/10.1007\/s00259-020-05174-2 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"42708_CR54","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/brain\/awv112","volume":"138","author":"S Villeneuve","year":"2015","unstructured":"Villeneuve, S. et al. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: Statistical and pathological evaluation. Brain 138, 2020\u20132033. https:\/\/doi.org\/10.1093\/brain\/awv112 (2015).","journal-title":"Brain"},{"key":"42708_CR55","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.neuroimage.2011.07.098","volume":"59","author":"EC Mormino","year":"2012","unstructured":"Mormino, E. C. et al. Not quite PIB-positive, not quite PIB-negative: Slight PIB elevations in elderly normal control subjects are biologically relevant. Neuroimage 59, 1152\u20131160. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.07.098 (2012).","journal-title":"Neuroimage"},{"key":"42708_CR56","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","volume":"89","author":"M Scholl","year":"2016","unstructured":"Scholl, M. et al. PET imaging of tau deposition in the aging human brain. Neuron 89, 971\u2013982. https:\/\/doi.org\/10.1016\/j.neuron.2016.01.028 (2016).","journal-title":"Neuron"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42708-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42708-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42708-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T09:14:49Z","timestamp":1700558089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42708-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42708"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42708-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15779"}}